Trial Profile
A trial of lacosamide for the treatment of adult patients with resistant partial epilepsy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 22 Feb 2016 New trial record